FIELD: medicine, neurology.
SUBSTANCE: the present innovation deals with treating chronic cerebral ischemia and preventing its complications. It has been suggested to apply aplegin (10%-D,L-carnitine chloride solution) as a preparation for monotherapy for treating and preventing the progress of chronic cerebral ischemia. Monotherapy with aplegin provides rapid, complete and stable improvement of patient's state due to normalization of thrombocytic aggregation, erythrocytic deformability and their functional properties along with neuroprotective effect.
EFFECT: higher efficiency of therapy.
3 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR NORMALIZATION OF AGGREGATIVE PROPERTIES OF PLATELETS AND ERYTHROCYTES AND MORPHODENSITOMETRIC INDICES OF ERYTHROCYTES | 2003 |
|
RU2245145C1 |
| METHOD FOR PREDICTING EARLY CHRONIC CEREBRAL ISCHEMIA OF STAGES I AND II | 2003 |
|
RU2258933C2 |
| METHOD OF TREATING PATIENTS WITH STAGE I-II HYPERTENSIVE DISCIRCULATORY ENCEPHALOPATHY | 2009 |
|
RU2405591C1 |
| METHOD OF ISHEMIC CEREBROVASCULAR DISEASES TREATMENT | 2006 |
|
RU2327494C1 |
| METHOD OF CHRONIC ISHEMIC CEREBROVASCULAR DISEASES TREATMENT | 2018 |
|
RU2682867C1 |
| METHOD FOR PHYSIOTHERAPEUTIC TREATMENT OF VERTIGO | 2016 |
|
RU2637618C1 |
| METHOD OF REHABILITATION OF PATIENTS WITH CHRONIC CEREBRAL ISCHEMIA | 2019 |
|
RU2720162C1 |
| PREPARATION FOR TREATING DISCIRCULATORY ENCEPHALOPATHY | 2002 |
|
RU2197991C1 |
| METHOD OF ASSESSING INDIVIDUAL BIOAVAILABILITY OF NITRIC OXIDE IN CEREBRAL MICROANGIOPATHY (SMALL VESSEL DISEASE) | 2023 |
|
RU2812240C1 |
| METHOD OF TREATING DISCIRCULATORY ENCEPHALOPATHY | 2009 |
|
RU2430713C2 |
